Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody

Posner, 1995, Paraneoplastic syndromes, 353

Jaeckle, 1986, Intraventricular injection of paraneoplastic anti-Purkinje cell antibody in a rat model, Neurology, 6, 332

Tanaka, 1995, Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss, Clin Neurol Neurosurg, 97, 95, 10.1016/0303-8467(95)00005-5

Tanaka, 1996, HLA A24 in paraneoplastic cerebellar degeneration with anti-Yo antibody, Neurology, 47, 606, 10.1212/WNL.47.2.606

Rammensee, 1995, MHC ligands and peptide motifs; first listing, Immunogenet, 41, 178, 10.1007/BF00172063

Tanaka, 1994, Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration, J Neurol Sci, 127, 153, 10.1016/0022-510X(94)90067-1

Kubo, 1994, Definition of specific peptide motifs for four major HLA-A alleles, J Immunol, 3913, 10.4049/jimmunol.152.8.3913

Giometto, 1997, Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system, Neuropathol Appl Neurobiol, 23, 468, 10.1111/j.1365-2990.1997.tb01323.x

Haridas, 1995, Changes in LAK susceptibility of tumor cells as their MHC class I antigen expression levels regenerate after treatment at pH 3.0, Immunol Lett, 44, 7, 10.1016/0165-2478(94)00179-U

Rensing-Ehl, 1996, Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway, Eur J Immunol, 26, 2271, 10.1002/eji.1830260945

Tanaka, 1998, Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody, J Neurol Sci, 161, 88, 10.1016/S0022-510X(98)00257-3

Yang, 1995, Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo, J Immunol, 155, 2564, 10.4049/jimmunol.155.5.2564

Davenport, 1996, Reverse immunogenetics: from HLA-disease associations to vaccine candidates, Mol Med Today, 2, 38, 10.1016/1357-4310(96)88757-0

Albert, 1998, Tumor-specific killer cells in paraneoplastic cerebellar degeneration, Nature Med, 4, 1321, 10.1038/3315